Steven R. Ripa

Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid-Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched, Randomized, Double-Blind, Placebo-Controlled Study

Deborah J. Steiner, Steve Sitar, Warren Wen et al. · Journal of Pain and Symptom Management · 2011 · 109 citations

Medicine, Pharmacotherapy, Pain Management +16

Efficacy and Safety of Buprenorphine Transdermal System (BTDS) for Chronic Moderate to Severe Low Back Pain: A Randomized, Double-Blind Study

Deborah Steiner, Catherine Munera, M. Hale et al. · Journal of Pain · 2011 · 80 citations

Nursing, Pharmacotherapy, Pain Management +12

Buprenorphine Transdermal Delivery System in Adults with Persistent Noncancer-Related Pain Syndromes Who Require Opioid Therapy: A Multicenter, 5-Week Run-in and Randomized, Double-Blind Maintenance-of-Analgesia Study

Craig Landau, W. David Carr, Albert J. Razzetti et al. · Clinical Therapeutics · 2007 · 60 citations

Nursing, Pharmacotherapy, Pain Management +14

A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain

Warren Wen, Steve Sitar, Shau Yu Lynch et al. · Expert Opinion on Pharmacotherapy · 2015 · 36 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A Randomized, Placebo-Controlled Study of the Impact of the 7-Day Buprenorphine Transdermal System on Health-Related Quality of Life in Opioid-Naïve Patients With Moderate-to-Severe Chronic Low Back Pain

Aaron Yarlas, K. Miller, Warren Wen et al. · Journal of Pain · 2012 · 33 citations

Medicine, Pharmacology, Pharmacotherapy +15